Abstract
Platinum(IV) prodrug overcomes acquired resistance to cisplatin in prostate cancer by inhibiting fatty acid oxidation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1257-1259 |
| Number of pages | 3 |
| Journal | ACS Central Science |
| Volume | 9 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 26 2023 |
ASJC Scopus subject areas
- General Chemistry
- General Chemical Engineering